President Trump signed an executive order Saturday that eases restrictions on the research of the psychedelics including the drug ibogaine, which is used in some countries to treat post-traumatic stress disorder.
Watch: Trump signs executive order easing U.S. restrictions on psychedelic research
Categories: News